Cargando…

Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach

Detalles Bibliográficos
Autores principales:	López-Viña, Antolín, Diaz Campos, Rocio M., Trisan Alonso, Andrea, Melero Moreno, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Allergy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872189/ https://www.ncbi.nlm.nih.gov/pubmed/36704752 http://dx.doi.org/10.3389/falgy.2022.1119941

Ejemplares similares

Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
por: López-Viña, Antolín, et al.
Publicado: (2022)

Molecular T2 asthma phenotypes are stable but heterogeneous: the usefulness of periostin for endotyping
por: Bobolea, Irina, et al.
Publicado: (2023)

Determinants of uncontrolled allergic rhinitis in Kinshasa hospitals
por: Kakobo, Patricia K., et al.
Publicado: (2023)

Corrigendum: Interactions of Bacteriophages and Bacteria at the Airway Mucosa: New Insights Into the Pathophysiology of Asthma
por: Tzani-Tzanopoulou, Panagiota, et al.
Publicado: (2022)

COVID-19, Eosinophils, and Biologicals for Severe Asthma
por: Lombardi, Carlo, et al.
Publicado: (2022)

Multiple reasons underlaying uncontrolled disease in the majority of chronic rhinosinusitis patients
por: Viskens, An-Sofie, et al.
Publicado: (2022)

Accreditation of specialized asthma units for adults in Spain: an applicable experience for the management of difficult-to-control asthma
por: Cisneros, Carolina, et al.
Publicado: (2017)

Editorial: Microbiota and asthma
por: Bautista-Becerril, Brandon, et al.
Publicado: (2023)

The role of the respiratory microbiome in asthma
por: Campbell, Christina D., et al.
Publicado: (2023)

Asthma Phenotypes and Host Risk Factors Associated With Various Asthma-Related Outcomes in Health Workers
por: Mwanga, Hussein H., et al.
Publicado: (2021)

Immunobiology of Steroid-Unresponsive Severe Asthma
por: Marshall, Courtney Lynn, et al.
Publicado: (2021)

Inflammatory Remission in T2 Severe Asthma
por: Rial, Manuel J., et al.
Publicado: (2022)

Immunogenetics and pharmacogenetics of allergic asthma in Africa
por: Mabelane, Tshegofatso, et al.
Publicado: (2023)

Asthma routinization, family asthma management, caregiver depressive symptoms, and medication adherence in Head Start preschool children
por: Lu, Monica A., et al.
Publicado: (2023)

Basophil Activation Test as a Biomarker for Taxanes Anaphylaxis
por: De Campos, Lucila, et al.
Publicado: (2022)

Pharmacological Rationale for Targeting IL-17 in Asthma
por: Rahmawati, Siti Farah, et al.
Publicado: (2021)

Editorial: Airway remodeling in asthma—what is new?
por: Yamasaki, Akira
Publicado: (2023)

Environmental allergen reduction in asthma management: an overview
por: Pham, Duy Le, et al.
Publicado: (2023)

Plausible Role of Asthma Biological Modifiers in the Treatment of Eosinophilic Esophagitis
por: Olsen, Timothy C, et al.
Publicado: (2021)

Purinergic Receptors in the Airways: Potential Therapeutic Targets for Asthma?
por: Thompson, Rebecca J., et al.
Publicado: (2021)

New Insights on the Role of pentraxin-3 in Allergic Asthma
por: Koussih, Latifa, et al.
Publicado: (2021)

Role of airway epithelial cell miRNAs in asthma
por: Boateng, Eistine, et al.
Publicado: (2022)

Paroxysmal dyspnoea in asthma: Wheeze, ILO or dysfunctional breathing?
por: Crawford, A. L., et al.
Publicado: (2022)

Risk Assessment in Drug Hypersensitivity: Detecting Small Molecules Which Outsmart the Immune System
por: Pichler, Werner J., et al.
Publicado: (2022)

Maternal and paternal tuberculosis is associated with increased asthma and respiratory symptoms in their offspring: a study from Northern Europe
por: Gyawali, Sanjay, et al.
Publicado: (2023)

Respiratory Viral and Bacterial Factors That Influence Early Childhood Asthma
por: Mthembu, Nontobeko, et al.
Publicado: (2021)

Gaps in asthma diagnosis and treatment in low- and middle-income countries
por: Barne, Monica
Publicado: (2023)

Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
por: Dubini, Marco, et al.
Publicado: (2023)

Bringing the treatable traits approach to primary care asthma management
por: Pfeffer, Paul E., et al.
Publicado: (2023)

Impact of Therapeutics on Unified Immunity During Allergic Asthma and Respiratory Infections
por: Flores-Torres, Armando S., et al.
Publicado: (2022)

Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives
por: Margelidon-Cozzolino, Victor, et al.
Publicado: (2022)

Interactions of Bacteriophages and Bacteria at the Airway Mucosa: New Insights Into the Pathophysiology of Asthma
por: Tzani-Tzanopoulou, Panagiota, et al.
Publicado: (2021)

Corrigendum: Fish Allergy Around the World—Precise Diagnosis to Facilitate Patient Management
por: Kalic, Tanja, et al.
Publicado: (2021)

Immunoglobulin E-Dependent Activation of Immune Cells in Rhinovirus-Induced Asthma Exacerbation
por: Kawakami, Toshiaki, et al.
Publicado: (2022)

Impact of COVID-19 lockdown on children with asthma in Jordan: a parental questionnaire
por: Al-Iede, Montaha, et al.
Publicado: (2021)

Deletion of Miro1 in airway club cells potentiates allergic asthma phenotypes
por: Bruno, Sierra, et al.
Publicado: (2023)

Youth and caregiver asthma functioning and quality of life throughout the COVID-19 pandemic
por: Sinisterra, Manuela, et al.
Publicado: (2023)

Association Between Asthma and Migraine: A Systematic Review and Meta-Analysis of Observational Studies
por: Kang, Lin-Lin, et al.
Publicado: (2021)

Performance of Three Asthma Predictive Tools in a Cohort of Infants Hospitalized With Severe Bronchiolitis
por: C. Fabiano Filho, Ronaldo, et al.
Publicado: (2021)

Real-World clinical outcomes of asthma patients switched from reslizumab to mepolizumab or benralizumab
por: Walsh, Laura J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5vfka9tn1oh98ba67bli8u5peg